Literature DB >> 9316014

Recovery of spatial learning by grafts of a conditionally immortalized hippocampal neuroepithelial cell line into the ischaemia-lesioned hippocampus.

J D Sinden1, F Rashid-Doubell, T R Kershaw, A Nelson, A Chadwick, P S Jat, M D Noble, H Hodges, J A Gray.   

Abstract

Transient global cerebral ischaemia in rats causes relatively circumscribed and specific damage to the CA1 pyramidal cells of the dorsal hippocampus, along with a cognitive deficit manifest as difficulties in the performance of a range of spatial learning and memory tasks. Our previous studies have shown that restoration of behavioural performance in ischaemic rats by neural grafts taken relatively late in fetal development occurs only after local replacement of cells homotypic to those lost through the ischaemic insult. This lesion-plus-behaviour model therefore offers a powerful means for establishing whether multipotent embryonic neuroepithelial cells will engraft the damaged CA1, develop into appropriate neuronal phenotypes and produce behavioural recovery. Here we report that, in rats subjected to 15 min of global cerebral ischaemia, intrahippocampal implants of a conditionally immortal, multipotent cell line, directly derived from the embryonic day 14 hippocampal neuroepithelium of the H-2Kb-tsA58 transgenic mouse, selectively repopulated the lesioned CA1 pyramidal layer and restored ischaemia-induced deficits in acquisition of a hidden platform location in the Morris water maze.

Entities:  

Mesh:

Year:  1997        PMID: 9316014     DOI: 10.1016/s0306-4522(97)00330-8

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  21 in total

1.  Cholinesterase inhibitors ameliorate spatial learning deficits in rats following hypobaric hypoxia.

Authors:  Sangu Muthuraju; Panchanan Maiti; Preeti Solanki; Alpesh Kumar Sharma; Shashi Bala Singh; Dipti Prasad; Govindasamy Ilavazhagan
Journal:  Exp Brain Res       Date:  2010-05-11       Impact factor: 1.972

2.  A chronic 1 year assessment of MRI contrast agent-labelled neural stem cell transplants in stroke.

Authors:  M Modo; J S Beech; T J Meade; S C R Williams; J Price
Journal:  Neuroimage       Date:  2008-06-25       Impact factor: 6.556

3.  Attachment of stem cells to scaffold particles for intra-cerebral transplantation.

Authors:  Ellen Bible; David Y S Chau; Morgan R Alexander; Jack Price; Kevin M Shakesheff; Michel Modo
Journal:  Nat Protoc       Date:  2009-09-17       Impact factor: 13.491

4.  Memory and long-term potentiation (LTP) dissociated: normal spatial memory despite CA1 LTP elimination with Kv1.4 antisense.

Authors:  N Meiri; M K Sun; Z Segal; D L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

Review 5.  Innovative strategies in the management of acute stroke.

Authors:  Lawrence R Wechsler
Journal:  Curr Cardiol Rep       Date:  2002-03       Impact factor: 2.931

6.  Stem cell transplantation for enhancement of learning and memory in adult neurocognitive disorders.

Authors:  Ben Waldau
Journal:  Aging Dis       Date:  2010-08-01       Impact factor: 6.745

Review 7.  Cell therapies for traumatic brain injury.

Authors:  Matthew T Harting; James E Baumgartner; Laura L Worth; Linda Ewing-Cobbs; Adrian P Gee; Mary-Clare Day; Charles S Cox
Journal:  Neurosurg Focus       Date:  2008       Impact factor: 4.047

Review 8.  Stem cells for ischemic brain injury: a critical review.

Authors:  Terry C Burns; Catherine M Verfaillie; Walter C Low
Journal:  J Comp Neurol       Date:  2009-07-01       Impact factor: 3.215

9.  Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils.

Authors:  J Liu; K Solway; R O Messing; F R Sharp
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

10.  c-MycERTAM transgene silencing in a genetically modified human neural stem cell line implanted into MCAo rodent brain.

Authors:  Lara Stevanato; Randolph L Corteling; Paul Stroemer; Andrew Hope; Julie Heward; Erik A Miljan; John D Sinden
Journal:  BMC Neurosci       Date:  2009-07-21       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.